Cargando…
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
Metabolic reprogramming is a hallmark of cancer progression. Metabolic activity supports tumorigenesis and tumor progression, allowing cells to uptake essential nutrients from the environment and use the nutrients to maintain viability and support proliferation. The metabolic pathways of malignant c...
Autores principales: | Yu, Zhuoya, Zhou, Xiangxiang, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437558/ https://www.ncbi.nlm.nih.gov/pubmed/35771627 http://dx.doi.org/10.1158/0008-5472.CAN-22-0917 |
Ejemplares similares
-
The functions and clinical significance of circRNAs in hematological malignancies
por: Zhou, Xiangxiang, et al.
Publicado: (2020) -
Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy
por: Zhang, Leqiang, et al.
Publicado: (2022) -
Therapeutic Advances in Immunotherapies for Hematological Malignancies
por: Nogami, Ayako, et al.
Publicado: (2022) -
The Research Advances of Aptamers in Hematologic Malignancies
por: Liao, Yongkang, et al.
Publicado: (2023) -
Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
por: Raza, Yasharah, et al.
Publicado: (2022)